Pancreapar Liquid
NDC Package 44911-0420-1
Package Information
Pancreapar (syzygium jambolanum, glandula suprarenalis suis, hydrastis canadensis, hypophysis suis, pancreas suis, phaseolus, aceticum acidum, lacticum acidum, phosphoricum acidum, phosphorus, uranium nitricum) liquids is for temporary relief of thirst, weakness and feebleness with weight loss, frequent urination, weakness and fatigue with lethargy.**These statements are based upon traditional homeopathic practice. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0420.
Identification & Billing
Clinical Specifications
- ACETIC ACID 12 [hp_X]/mL
- GOLDENSEAL 6 [hp_X]/mL
- KIDNEY BEAN 9 [hp_X]/mL
- LACTIC ACID 12 [hp_X]/mL
- PHOSPHORIC ACID 12 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND 6 [hp_X]/mL
- SUS SCROFA PANCREAS 6 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND 6 [hp_X]/mL
- SYZYGIUM CUMINI SEED 3 [hp_X]/mL
- URANYL NITRATE HEXAHYDRATE 12 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0420 - Pancreapar
- 44911-0420-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0420 - Pancreapar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0420-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Pancreapar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains acetic acid; goldenseal; kidney bean; lactic acid; phosphoric acid; phosphorus; sus scrofa adrenal gland; sus scrofa pancreas; sus scrofa pituitary gland; syzygium cumini seed; uranyl nitrate hexahydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on August 04, 2017.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911042001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.